My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

EID Parry (India) fixes record date interim dividend
Feb 21,2017

EID Parry (India) has fixed 06 March 2017 as the Record Date for the purpose of Payment of Interim Dividend.

Interim Dividend will be paid on or before 15 March 2017.

Powered by Capital Market - Live News

Marksans Pharma rallies 25.86% in two sessions
Feb 21,2017

Meanwhile, the S&P BSE Sensex was down 15.97 points, or 0.06%, to 28,645.61.

High volumes were witnessed on the counter. On the BSE, 33.95 lakh shares were traded on the counter so far as against the average daily volumes of 5.02 lakh shares in the past one quarter. The stock had hit a high of Rs 52.40 and a low of Rs 49.30 so far during the day.

The stock had hit a 52-week high of Rs 58.30 on 6 October 2016 and a 52-week low of Rs 33.45 on 1 March 2016. The stock had outperformed the market over the past one month till 20 February 2017, advancing 23.92% compared with the Sensexs 6.02% rise. The scrip had also outperformed the market over the past one quarter advancing 13.92% as against the Sensexs 9.6% rise.

The small-cap company has equity capital of Rs 40.93 crore. Face value per share is Rs 1.

Shares of Marksans Pharma rallied 25.86% in two trading sessions from its close of Rs 40.60 on 17 February 2017, after the company announced during market hours yesterday, 20 February 2017 that its Goa plants inspection by UK MHRA from 14th February 2017 to 17 February 2017 was completed without any critical observations. The stock had rallied 19.95% to settle at Rs 48.70 yesterday, 20 February 2017 post announcement.

Marksans Pharmas consolidated net profit fell 37% to Rs 11.30 crore on 1% decrease in net sales to Rs 215.24 in Q3 December 2016 over Q3 December 2015.

Marksans Pharma is a global pharmaceutical company. It is engaged in research & development (R&D) and offers CRAMS (contract research and manufacturing services) to global pharmaceutical companies.

Powered by Capital Market - Live News

Ramco Systems advances as US based firm deploys companys aviation suite
Feb 21,2017

The announcement was made during market hours today, 21 February 2017.

Meanwhile, the S&P BSE Sensex was down 16.02 points or 0.06% at 28,645.56.

On the BSE, 31,000 shares were traded on the counter so far as against the average daily volumes of 55,423 shares in the past one quarter. The stock had hit a high of Rs 369 and a low of Rs 341.50 so far during the day.

The stock had hit a 52-week high of Rs 814 on 3 May 2016 and a 52-week low of Rs 286 on 15 December 2016. The stock had underperformed the market over the past one month till 20 February 2017, sliding 6.61% compared with the Sensexs 6.02% rise. The scrip had also underperformed the market over the past one quarter, declining 5.19% as against the Sensexs 9.6% rise.

The small-cap company has equity capital of Rs 30.35 crore. Face value per share is Rs 10.

The United States largest independently owned and operated, membership-supported air medical service, Air Evac EMS, Inc., announced the successful implementation of Ramco Systems aviation software, Ramco Aviation V5.7, for its maintenance and engineering operations across 135 air bases.

Air Evac is a subsidiary of Air Medical Group Holdings, the worIds largest independent provider of air medical services and a Ramco Aviation customer.

Ramco Systems reported consolidated net profit of Rs 3.02 crore in Q3 December 2016, compared with net loss of Rs 1.17 crore in Q2 September 2016. Net sales declined 0.3% to Rs 112.82 crore in Q3 December 2016 over Q2 September 2016.

Ramco is a fast growing enterprise software player disrupting the market with its multi-tenanted cloud and mobilen++based enterprise software in the area of HCM and Global Payroll, ERP and M&E MRO for aviation.

Powered by Capital Market - Live News

Ramco Systems partners with Air Evac EMS Inc.
Feb 21,2017

The United States largest independently owned and operated, membership-supported air medical service, Air Evac EMS, Inc., announced the successful implementation of Ramco Systems aviation software, Ramco Aviation V5.7, for its maintenance andengineering operations across 135 air bases.

The upgrade also marks the migration of seven years of Air Evacs data and 120+ customized reports into a multi-organizational unit platform that integrates with in-house systems for flight tracking.

Powered by Capital Market - Live News

Suraj Products announces change in directorate
Feb 21,2017

Suraj Products announced that the Board of Directors vide their meeting dated 14 February 2017 has appointed Neha Singhania, as an Independent Director of the Company with effect from 14 February 2017 in the casual vacancy caused due to resignation of S. N. Kabra.

Powered by Capital Market - Live News

M&A and InvITs in Infrastructure Sector to Account 12% of Total Equity Requirement
Feb 21,2017

Infrastructure deals particularly in road sector in the form of Infrastructure Investment Trusts (InvITs) is likely to gain traction in 2017, says India Ratings and Research (Ind-Ra). The agency estimates INR0.4 trillion of funds to be raised by infrastructure sector from 25 major mergers and acquisitions (M&A) and InvITS in 2017. While this could support several cash strapped infrastructure developers, the high indebtedness and weak cash flow are likely to keep leverage at 7x-8x over FY18-FY20, marginally lower than the FY16 level of 8.5x. Ind-Ras analysis of 66 large borrowers in the infrastructure sector reflects that the deals would contribute only 12% of the total equity requirement of INR3 trillion-INR4 trillion to deleverage to a sustainable level of 4x-5x.

Road: Ind-Ra expects INR173 billion of funds to be raised by performing assets in the road sector through M&A deals and InvITs in 2017, due to monetisation of road projects (toll operate transfer) and tax efficiency. This contributes one-third of the total equity requirement to deleverage to a sustainable level. The sector is likely to benefit from the Union Budget 2017-18 budgetary allocation of INR0.9 trillion for road and highway segment, with an aim to stimulate private sector participation in the sector. This in Ind-Ras view would largely benefit the non-stressed players with a strong balance sheet. M&A activities in the stressed assets in the road sector are unlikely to witness a pick-up due to disagreements in valuations and the extent of debt hair-cuts required.

Thermal Power: Ind-Ra believes that domestic consolidation in the thermal sector will continue in 2017. The sector has been impacted by a sub-optimal plant load factor, weak cash flows and poor credit profile of distribution companies. An increase in the industrial electricity demand, an increasing pace of signing of new power purchase agreements and the successful implementation of Ujwal Discom Assurance Yojana scheme would aid the ailing sector from a further distress. A potential equity of INR60 billion is likely to be unlocked from M&A deals in the thermal power sector. This in Ind-Ras view is negligible, since it accounts a mere 4% of the total equity requirement for deleveraging corporates to a sustainable level.

Renewable Energy (Wind and Solar): Ind-Ra expects INR69 billion of equity released from the renewable energy sector to contribute one-third of the sectors total equity requirement to deleverage to a sustainable level. The Union Budget thrust on the second phase of development of 20GW solar energy and solar tariffs approaching grid parity is likely to garner investors interest in to the sector. On the contrary, deal activities will be subdued in the wind energy sector due to halving of accelerated depreciation to 40% and lapse of generation-based incentives effective 1 April 2017.

Other Infrastructure: Ind-Ra believes M&A activities and InvITs in other sectors such as transmission, airport and ports are expected to unlock equity worth INR59 billion. Ind-Ras view M&A activities in these sectors to remain subdued in 2017 as majority of the consolidation in these sectors has already been taken.

Powered by Capital Market - Live News

Deccan Gold Mines allots 3.4 lakh equity shares
Feb 21,2017

Deccan Gold Mines announced that on 21 February 2017 the Company has allotted 350,000 fully paid equity shares of Re.1/- each on conversion of employee stock options under Deccan Gold Mines Limited Employee Stock Option Scheme, 2014.

Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs.90,327,375/- consisting of 90,327,375 equity shares of Re.1/- each to Rs. 90,677,375/- consisting of 90,677,375 equity shares of Re. 1/- each.

Powered by Capital Market - Live News

Nihar Info Global provides business update
Feb 21,2017

Nihar Info Global announced that the Company has started selling the products in the various states of Andra Pradesh, Telangana, Rajasthan, Gujrat through the network of Common Service Centers and Kiyossk Centres.

The Company is integrating the application for the same and would soon begin the operations by which it would be selling in about 20000 centres.

In this regards, the Company has signed an agreement with Kiyossk Solutions.

Powered by Capital Market - Live News

HOV Services spurts to 52-week high
Feb 21,2017

The announcement was made before market hours today, 21 February 2017.

Meanwhile, the S&P BSE Sensex was down 41.29 points or 0.14% at 28,620.29.

On the BSE, 2.25 lakh shares were traded on the counter so far as against the average daily volumes of 65,808 shares in the past one quarter. The stock had hit a high of Rs 173 so far during the day, which is a 52-week high for the counter. The stock hit a low of Rs 160 so far during the day.

The stock had hit a 52-week low of Rs 75.10 on 16 March 2016. The stock had outperformed the market over the past one month till 20 February 2017, advancing 11.28% compared with the Sensexs 6.02% rise. The scrip had also outperformed the market over the past one quarter, gaining 58.34% as against the Sensexs 9.6% rise.

The small-cap company has equity capital of Rs 12.53 crore. Face value per share is Rs 10.

HOV Services net profit declined 18.7% to Rs 0.39 crore on 2.6% decline in net sales to Rs 3.36 crore in Q3 December 2016 over Q3 December 2015.

HOV Services, operates as a hybrid between investment and diversified services corporation. The company has grown over the last decade plus through series of key acquisitions.

Powered by Capital Market - Live News

Siemens gains after securing order
Feb 21,2017

The announcement was made after market hours yesterday, 20 February 2017.

Meanwhile, the S&P BSE Sensex was up 20.52 points, or 0.07%, to 28,682.10.

On the BSE, 10,000 shares were traded on the counter so far as against the average daily volumes of 23,188 shares in the past one quarter. The stock had hit a high of Rs 1,237 and a low of Rs 1,228.05 so far during the day.

The stock had hit a 52-week high of Rs 1,355.40 on 25 July 2016 and a 52-week low of Rs 973.20 on 29 February 2016. The stock had underperformed the market over the past one month till 20 February 2017, advancing 5.22% compared with the Sensexs 6.02% rise. The scrip had also underperformed the market over the past one quarter advancing 8.71% as against the Sensexs 9.6% rise.

The large-cap company has equity capital of Rs 71.22 crore. Face value per share is Rs 2.

Siemens and Siemens Rail Automation Ltd. S.A.U Spain have jointly won an order worth Rs 287 crore, out of which Siemens share is Rs 146 crore. Siemens will supply state-of-the-art signaling technology for the first two metro lines of the Nagpur Metro i.e. the North-South and the East-West corridors.

The project comprises the deployment and installation of the Siemens communications-based train control (CBTC) solution Trainguard MT for 38.2 kilometers of double track with 36 stations and 2 depots, as well as onboard equipment for 23 three-cars trains.

Siemens net profit rose 43.8% to Rs 160.01 crore on 1.4% decline in net sales to Rs 2234.38 crore in Q1 December 2016 over Q1 December 2015.

Siemens focuses on the areas of electrification, automation and digitalization. As on 31 December 2016, Siemens AG held 75% stake in Siemens.

Powered by Capital Market - Live News

MMTC appoints directors
Feb 21,2017

MMTC announced that the Board of Directors has approved the appointment of Dr. Jayant Dasgupta and Rajendrasinh Rattansinh Jadeja as Part Time non-official Directors- on the Board of the Company, for a period of 3 years in accordance with the Office Order dated 27 January 2017 of Department of Commerce, Ministry of Commerce & Industry.

Powered by Capital Market - Live News

Simplex Papers appoints director
Feb 21,2017

Simplex Papers announced that the Board of Directors of the Company through a circular resolution on 20 February 2017 has appointed Manish Harshey as an Additional Director of the Company with effect from 20 February 2017 to hold office as an Independent Director of the Company.

Powered by Capital Market - Live News

Karnataka Bank gains after tie-up with Daimler India Commercial Vehicles
Feb 21,2017

The announcement was made after market hours yesterday, 20 February 2017.

Meanwhile, the BSE Sensex was up 19.01 points, or 0.07%, to 28,680.59.

On the BSE, so far 1.81 lakh shares were traded in the counter, compared with average daily volumes of 2.76 lakh shares in the past one quarter. The stock had hit a high of Rs 124.45 and a low of Rs 122.35 so far during the day.

The stock hit a 52-week high of Rs 134.15 on 24 October 2016. The stock hit a 52-week low of Rs 69.07 on 29 February 2016.

The mid-cap private sector bank has equity capital of Rs 282.70 crore. Face value per share is Rs 10.

Karnataka Bank has entered into a memorandum of understanding (MoU) with Daimler India Commercial Vehicles (DICV) for extending finance facilities to customers to purchase commercial vehicles manufactured by the company. DICV is one of the leading manufacturing Companies of commercial vehicles in India with a pan-India presence. Bharat Benz is the Indian truck brand of Daimler AG, the worlds largest commercial vehicle manufacturer and inventor of the truck. The MoU was signed at Karnataka Banks head office at Mangaluru. DICV has nominated Karnataka Bank as preferred financier for extending finance to purchase of commercial vehicles manufactured by the company.

Net profit of Karnataka Bank declined 29.3% to Rs 68.52 crore on 6.4% rise in operating income to Rs 1457.52 crore in Q3 December 2016 over Q3 December 2015.

Powered by Capital Market - Live News

Umang Dairies declines on profit booking
Feb 21,2017

Meanwhile, the S&P BSE Sensex was up 13.57 points or 0.05% at 28,675.15.

On the BSE, 33,000 shares were traded on the counter so far as against the average daily volumes of 31,884 shares in the past one quarter. The stock had hit a high of Rs 85.35 and a low of Rs 81.50 so far during the day.

The stock had hit a record high of Rs 101 on 30 October 2016 and a 52-week low of Rs 52 on 29 February 2016. The stock had outperformed the market over the past one month till 20 February 2017, advancing 11.86% compared with the Sensexs 6.02% rise. The scrip had also outperformed the market over the past one quarter, gaining 17.72% as against the Sensexs 9.6% rise.

The small-cap company has equity capital of Rs 11 crore. Face value per share is Rs 5.

Shares of Umang Dairies had rallied 16.52% to settle at Rs 85.35 yesterday, 20 February 2017 after promoter shareholding rejig via bulk deal mechanism on the stock exchanges.

Accurate Finman Services sold 11.50 lakh shares of Umang Dairies to Juggilal Kamlapat Udyog at Rs 73.75 per share in a bulk deal on the BSE on 20 February 2017. On the same day, Accurate Finman Services offloaded 10.50 lakh shares to Bengal & Assam Company at Rs 74.25 a piece in a bulk deal on the NSE.

Promoter entities Accurate Finman Services, Juggilal Kamlapat Udyog and Bengal & Assam Company held 11.81%, 12.27% and 45.1% stake in Umang Dairies end December 2016.

Umang Dairies reported net loss of Rs 0.18 crore in Q3 December 2016 compared with net profit of Rs 2.79 crore in Q3 December 2015. Net sales rose 9% to Rs 36.43 crore in Q3 December 2016 over Q3 December 2015.

Umang Dairies is a dairy product manufacturing company. It produces and markets skimmed milk powder, butter, pure ghee, varieties of dairy whiteners and premixes compatible with tea & coffee vending machines and liquid milk in poly pouches for retail and institutional customers.

Powered by Capital Market - Live News

Pharma industry to reach USD 55 bn in 3 years; medical tourism major growth driver: ASSOCHAM-IITTM study
Feb 21,2017

Indian pharmaceuticals market is expected to touch US$ 55 billion by 2020 from the current level of US$ 36.7 billion in 2016 growing at a compound annual growth rate (CAGR) of 15.92 per cent, according to ASSOCHAM-IITTM joint study.

Indian pharmaceuticals market increased at a CAGR of 17.46 per cent during 2005-16 with the market increasing from US$ 6 billion in 2005 to US$ 36.7 billion in 2016. By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size, noted the study titled `Medical Value Travel (MVT),` jointly conducted by ASSOCHAM and research firm Indian Institute of Tourism and Travel Management (IITTM).

According to joint report, Indian Health Care is expected to rise at a rate of CAGR of 29% during 2015-20 to US $280 billion with rising income, greater health awareness, increased precedence of lifestyle diseases and improved access to insurance,

The year 2015 witnessed the growth of 140% of foreign tourist`s arrival on medical visa from the year 2013, where more than 50, 000 people visited India on medical visa. This number rose to approx 1,34,000 in 2015. In fact, the number of foreign tourist`s arrival on a medical attendant visa also doubled from 2013 to 2015, increasing from 42,000 odd in 2013 to more than 99,000 in 2015, adds the study.

The study reveals that in the first 6 months of 2016 alone, close to a lakh foreign tourists have arrived on a medical visa making it a very lucrative market. The top most countries availing medical visa were Bangladesh, Afghanistan, Maldives, Republic of Korea and Nigeria.

The majority of the patients coming to India for treatment are from the Middle East, Africa, Bangladesh, Afghanistan, Maldives, Pakistan, Bhutan and Sri Lanka for its expertise in cardiac and orthopaedic procedures, in addition to other specialised areas like neuro-surgeries, cancer treatment and organ transplantation. India is also attracting medical tourists looking for the traditional system of medicine available in India, noted the study.

The ability to offer holistic medical services such as Unani, Yoga, Meditation, Ayurveda, and Homeopathic treatments (AYUSH) is also a huge attraction.

There are less numbers of accredited hospitals in India. Thailand being a smaller nation has 55 JCI accredited medical facilities. Lack of enough accredited medical facilities decreases the supply potentials of India as a medical tourism hub. Though the cost of treatment in India is less but there is high cost of accommodation which creates a barrier for low income group patients. There is also lack of proper regulatory and review framework related to medical tourism giving way to many legal and ethical issues.

Many problems arise due to lack of synergy between various stakeholders. Stringent medical visa rules also create a barrier as it makes the process of entering in the country difficult. This issue is high on radar due to the influx of medical tourist from ISIS hit countries which creates huge security issue for India, highlighted the joint study.

The government of India has recognized the potential of medical tourism and has come up with supporting policies. The Indian Ministry of Tourism is actively promoting medical tourism through overseas road shows where market development assistance (MDA) is provided to medical and wellness tourism service providers to encourage overseas promotion. The government has introduced medical visa to govern medical tourism. In order to further expand the healthcare system and enhance its quality, the government also actively provides incentives and giving special approvals to foreign firms for direct investments.

Indias cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge to India over others. Growing number of medical facilities are realizing the importance of accreditation and certification leading many labs and hospitals taking up accreditation and certification. This could increase the number of accredited facilities in India.

Powered by Capital Market - Live News